Company News for August 4, 2022
- Shares of Moderna, Inc. MRNA jumped 16% after announcing a $3 billion share buyback plan.
- REGN shares of Regeneron Pharmaceuticals, Inc. rose 5.9% after reporting Q2 2022 earnings of $9.77 per share, beating Zacks consensus estimate of $8.53 per share .
- Shares of Horizon Therapeutics Public Limited Company HZNP fell 18.5% after reporting second-quarter 2022 revenue of $876.4 million, missing Zacks’ consensus estimate of $938.8 million.
- Exelon Corporation’s EXC shares fell 3.3% after reporting earnings of $0.44 per share in the second quarter of 2022, missing Zacks’ consensus estimate of $0.46 per share.
5 shares ready to double
Each was handpicked by a Zacks expert as the #1 preferred stock to earn +100% or more in 2021. Previous recommendations have skyrocketed +143.0%, +175.9%, + 498.3% and +673.0%.
Most of the stocks in this report fly under the radar on Wall Street, which provides a great opportunity to get in on the ground floor.
Today, check out these 5 potential home runs >>
Regeneron Pharmaceuticals, Inc. (REGN): Free Stock Analysis Report
Exelon Corporation (EXC): Free Stock Analysis Report
Moderna, Inc. (MRNA): Free Stock Analysis Report
Horizon Therapeutics Public Limited Company (HZNP): Free Stock Analysis Report
To read this article on Zacks.com, click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
